Valproate
| Valproate | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 143.20 g/mol [1] |
| Predicted LogP | 3.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C8H15O2- |
| IUPAC name | 2-propylpentanoate |
| SMILES | CCCC(CCC)C(=O)[O-] |
| InChI | InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)/p-1 |
| InChIKey | NIJJYAXOARWZEE-UHFFFAOYSA-M |
| PubChem CID | 3549980 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 9–16 hours |
| Metabolism | Liver—glucuronide conjugation 30–50%; mitochondrial β-oxidation over 40%; oxidation, hydroxylation, and dehydrogenation 15–20% |
| Excretion | Mostly via hepatic metabolism, <3% in urine |
| Routes of administration | Oral, intravenous |
Valproate (also known as 2-propylvalerate or Ccg-204971).
Chemistry
Stereochemistry []
Valproate is achiral.
Druglikeness
Lipinski's rule of five
Valproate matches Lipinski's rule of five.Pharmacology
MeSH Classification
- anticonvulsants (M0001382)
- enzyme inhibitors (M0007520)
- gaba agents (M0027993)
- antimanic agents (M0028007)
Medical side effects []
302 side effects listed on drug labels in SIDER 4.1 (valproate).
- Headache
- Nausea
- Asthenia
- Fatigue
- Tremor
- Somnolence
- Drowsiness
- Diplopia
- Vomiting
- Infection
- Diarrhoea
- Dizziness
- Thrombocytopenia
- Influenza
- Insomnia
- Decreased appetite
- Pain
- Dyspepsia
- Abdominal pain
- Abdominal cramps
- Gastrointestinal pain
- Nervousness
- Tension
- Amblyopia
- Ataxia
- Back pain
- Vision blurred
- Alopecia
- Nystagmus
- Coagulopathy
- Dermatitis
- Rash
- Body temperature increased
- Pharyngitis
- Weight decreased
- Mood swings
- Affect lability
- Injury
- Increased appetite
- Thinking abnormal
- Mental disability
- Oedema peripheral
- Muscle twitching
- Amnesia
- Bronchitis
- Constipation
- Rhinitis
- Sleep disorder
- Influenza like illness
- Depression
- Ecchymosis
- Spontaneous bruising
- Endocrine disorder
- Metabolic disorder
- Tinnitus
- Weight increased
- Paraesthesia
- Dyspnoea
- Neonatal disorder
- Drug interaction
- Pharmacokinetic interaction
- Aggression
- Agranulocytosis
- Anaphylactic shock
- Anaemia
- Aplastic anaemia
- Autism
- Enuresis
- Eosinophilia
- Toxic epidermal necrolysis
- Erythema multiforme
- Stevens-Johnson syndrome
- Folate deficiency
- Multiple fractures
- Fracture
- Hostility
- Hypersensitivity
- Hyponatraemia
- Inappropriate antidiuretic hormone secretion
- Leukopenia
- Lymphocytosis
- Osteopenia
- Osteoporosis
- Pancytopenia
- Bone marrow depression
- Polycystic ovaries
- Psychotic disorder
- Swelling
- Urinary tract infection
- Bone pain
- Menstruation irregular
- Porphyria acute
- Amenorrhoea
- Galactorrhoea
- Cutaneous vasculitis
- Photosensitivity reaction
- Agitation
- Excitement
- Hyperkinesia
- Developmental delay
- Congenital anomaly
- Bradycardia
- Hypofibrinogenaemia
- Emotional distress
- Deafness
- Hearing impaired
- Autism spectrum disorder
- Breast enlargement
- Pancreatitis acute
- Anaemia macrocytic
- Angioedema
- Anxiety
- Arrhythmia
- Arthralgia
- Musculoskeletal discomfort
- Myalgia
- Abnormal behaviour
- Mental disorder
- Blister
- Dermatitis bullous
- Vesiculobullous rash
- Breast disorder
- Catatonia
- Catatonic reaction
- Neck pain
- Chest pain
- Cognitive disorder
- Coma
- Confusional state
- Feeling abnormal
- Malaise
- Conjunctivitis
- Connective tissue disorder
- Contusion
- Cystitis
- Bladder pain
- Cystitis noninfective
- Cyst
- Dysphagia
- Drug eruption
- Dysarthria
- Osteoarthritis
- Arthropathy
- Dysgeusia
- Dysmenorrhoea
- Dysuria
- Ear disorder
- Ear pain
- Oedema
- Enzyme induction
- Epistaxis
- Eructation
- Erythema nodosum
- Extrapyramidal disorder
- Eye disorder
- Fanconi syndrome
- Renal tubular disorder
- Faecal incontinence
- Flatulence
- Furuncle
- Gastroenteritis
- Gastrointestinal disorder
- Gingival bleeding
- Glossitis
- Hallucination
- Atrioventricular block
- Haematemesis
- Haematoma
- Haemorrhage
- Haemoglobin
- Hiccups
- Hypertension
- Hypoaesthesia
- Hypoproteinaemia
- Hypotension
- Orthostatic hypotension
- Body temperature decreased
- Hypothermia
- Hypothyroidism
- Immune system disorder
- Incontinence
- Infertility male
- Learning disorder
- Muscle spasms
- Lethargy
- Cutaneous lupus erythematosus
- Mediastinal disorder
- Menstrual disorder
- Metrorrhagia
- Hypertonia
- Fungal infection
- Myelodysplastic syndrome
- Necrosis
- Neoplasm
- Nervous system disorder
- Neutropenia
- Otitis media
- Palpitations
- Pancreatitis
- Tooth abscess
- Personality disorder
- Petechiae
- Pleural effusion
- Pneumonia
- Polyp
- Polyuria
- Urine output increased
- Pruritus
- Aplasia pure red cell
- Seborrhoeic dermatitis
- Sinusitis
- Speech disorder
- Stomatitis
- Mouth ulceration
- Hyperhidrosis
- Sweating increased
- Tachycardia
- Tooth disorder
- Pollakiuria
- Urinary incontinence
- Urethral disorder
- Urinary tract disorder
- Urticaria
- Vaginal inflammation
- Vaginal infection
- Angiopathy
- Vasculitis
- Vasodilation procedure
- Vertigo
- Viral infection
- Dry mouth
- Encephalopathy
- Chills
- Polydipsia
- Hepatic failure
- Stupor
- Depressed level of consciousness
- CNS depression NOS
- Photophobia
- Hypokinesia
- Hepatic function abnormal
- Musculoskeletal stiffness
- Nuchal rigidity
- Amylase increased
- Serum amylase increased
- Bleeding time prolonged
- Drug level increased
- Injection site inflammation
- Injection site reaction
- Eye pain
- Injection site pain
- Prothrombin level increased
- Rash pustular
- Hyperreflexia
- Aspartate aminotransferase increased
- Alanine aminotransferase increased
- Dry skin
- Vascular anomaly
- Increased tendency to bruise
- Liver injury
- Traumatic liver injury
- Malnutrition
- Skin disorder
- Discomfort
- Ill-defined disorder
- Abdominal pain upper
- Asterixis
- Teratogenicity
- Disturbance in attention
- Memory impairment
- Abnormal dreams
- Euphoric mood
- Hepatotoxicity
- Cerebral atrophy
- Hepatic enzyme increased
- Parkinsonism
- Hepatobiliary disease
- Petit mal epilepsy
- Coagulation factor decreased
- Dry eye
- Systemic lupus erythematosus
- Rash maculo-papular
- Liver function test normal
- Pruritus generalised
- Dementia
- Coordination abnormal
- Visual impairment
- Abnormal vision
- Face oedema
- Hypovolaemia
- Abdominal discomfort
- Gastrointestinal tract irritation
- Cough
- Gait disturbance
- Tardive dyskinesia
- Cerebellar atrophy
- Administration site reaction
- Mental status changes
- Thyroid function test abnormal
- Muscular weakness
- Epidermal necrosis
- Vaginal haemorrhage
Indications
- Acquired immunodeficiency syndrome
- Aggression
- Bipolar disorder
- Bipolar I disorder
- Complex partial seizures
- Convulsion
- Convulsions generalised
- Decreased interest
- Dehydration
- Delusion of grandeur
- Depressed mood
- Disorders of urea cycle metabolism
- Drug interaction
- Epilepsy
- Fasting
- Flight of ideas
- Hepatic enzyme increased
- Hepatic function abnormal
- Hostility
- Hyperammonaemia
- Hyperammonaemic encephalopathy
- Hyperkinesia
- Irritability
- Loss of consciousness
- Major depressive disorder, single episode
- Mania
- Mania acute
- Manic episode
- Migraine
- Myoclonic epilepsy
- Nonketotic hyperglycinaemia
- Petit mal epilepsy
- Pregnancy
- Pressure of speech
- Psychotic disorder
- Somnolence
- Status epilepticus
- Systemic lupus erythematosus
- Thrombocytopenia
- Tonic-clonic seizures
- Urinary tract infection
Legal status []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3549980, Valproate. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3549980
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Product monograph brand safety updates. Health Canada. 7 July 2016. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/label-safety-assessment-update/product-monograph-brand-safety-updates.html
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 07:53:31 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 07:53:27 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 07:53:27 |
| gsrs | missing (no UNII) | 2026-11-20 07:53:27 |
| hmdb | missing (no HMDB id) | 2026-11-20 07:53:27 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 07:53:30 |
| pubchem | ok | 2026-11-20 07:53:27 |
| missing (no r/tripreports posts mention it) | 2026-11-20 07:53:27 | |
| sider | ok | 2026-11-20 07:53:28 |
| structure | ok | 2026-11-20 07:53:27 |
| wikipedia | ok | 2026-11-20 07:53:27 |